Screening of germline mutations in young Rwandan with breast cancer

Background: In Sub-Saharan Africa breast cancer is commonly detected at younger age and the profile is more aggressive with a high mortality rate compared to the European countries. It is suggested that African-specific genetic background plays a key role in this matter. The present study aimed at understanding the role of genetic factors in breast cancer development in young Rwandan.
Methods: We performed a massive parallel sequencing on Illumina MiSeq NGS sys-tem for the screening of 26 genes associated with hereditary breast cancer from 40 pa-tients under 35 years old from two University Teaching Hospitals in Kigali, Rwanda. Sanger sequencing was used to confirm pathogenic and likely pathogenic mutations. Results: Five patients out of 40 (12.5%) presented with pathogenic mutations includ-ing four patients (10%) carrying BRCA1 or BRCA2 pathogenic variants. One patient showed a missense likely pathogenic TP53 variant. We have also detected addi-tional missense, intronic, and 3’UTR variants of unknown significance in all study participants.

Conclusion: This preliminary study suggests that the frequency of germline mutations in young Rwandan patients with breast cancer is similar to the observations made in Caucasians. However, further large studies including patients and controls are needed to better understand the impact of genetic factors as well as the environmental risk fac-tors in the development of breast cancer in young Rwandans